Search
for
Sort by
Research 601–630 of 881
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Alopecia Areata
- The biology and genetics of curly hair
- Keratin expression by corneal and limbal stem cells during development
- Hair transplantation in burn scar alopecia
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Baricitinib: A Review in Severe Alopecia Areata
- Clinical Snippets
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial
- The Value of Long Hair Preview in Body Hair Transplantation
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- Trichoscopic features of frontal fibrosing alopecia: Results in 249 patients
- Alopecia Universalis Successfully Treated With Adalimumab
- A review of scalp camouflaging agents and prostheses for individuals with hair loss
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Clinical Description of Frontal Fibrosing Alopecia with Concomitant Lichen Planopilaris
- Hair loss during and after breast cancer therapy
- Hair changes due to zinc deficiency in a case of sucrose malabsorption
- Frontal fibrosing alopecia and genital Lichen sclerosus: Single‐center experience
- Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Frontal fibrosing alopecia in men: A multicenter study of 39 patients
- Characterization of the role of Facebook groups for patients who use scalp cooling therapy: a survey study
- The Relationship Between Patient-Reported Severity of Hair Loss and Health-Related Quality of Life and Treatment Patterns Among Patients with Alopecia Areata